Detalhe da pesquisa
1.
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.
Nat Biomed Eng
; 3(4): 264-280, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952988
2.
Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential.
Nanomedicine (Lond)
; 5(2): 181-92, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20148631
3.
Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics.
J Pharm Sci
; 98(2): 411-29, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18563780
4.
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
Endothelium
; 15(4): 189-201, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18663622